Argentum Medical, a leading medical device manufacturer in Geneva, Illinois, awarded Defense Logistics Agency contract worth up to $14.7 million


SILVERLON® burn dressings.

Argentum Medical is committed to supporting America’s veterans and active duty military and by participating in the ECAT program, we are able to positively impact the way we deliver medical products to these healthcare providers.

Argentum Medical, a medical device leader in silver-plated antimicrobial dressings, announced today that it has been awarded a five-year contract up to $14.7 million with the U.S. Department of Defense (DoD) Electronic Catalog System (ECAT). Effective August 2020, there are 62 Silverlon products added to provide government customers with greater access to antimicrobial dressings for use across wound care, surgical, vascular access and burn specialties.

The ECAT program is designed to evaluate products for value and performance and allows customers to browse, compare and order a wide range of approved products. It is the goal of the ECAT program to streamline procurement decisions to allow better, simpler access to contracted vendors.

“Argentum Medical is committed to supporting America’s veterans and active duty military and by participating in the ECAT program, we are able to positively impact the way we deliver medical products to these healthcare providers,” states Raul Brizuela, President & CEO of Argentum Medical. “As a U.S. manufacturer and distributor, we are proud to bring clinically supported technology and expand access to our product line.”

SILVERLON’S MILITARY HERITAGE

Developed for combat injuries, SILVERLON® antimicrobial technology is now used throughout the U.S. Military. As the evidence-based antimicrobial dressing available, SILVERLON® products contain 50 to 100 times more metallic silver ions than other silver-impregnated dressings.

Studies have shown SILVERLON® to be highly effective in hostile and austere military environments. The U.S. Army uses SILVERLON® wound-care technology extensively in the management of burn and blast injuries.

SILVERLON® is incorporated into numerous deployed Medical Tactical Combat Casualty Care kits and is also supplied in bulk to Combat and Support Hospitals and Tactical Forward Surgical Teams. It is also included in burn care protocols in the Joint Theater Trauma System Clinical Practice Guideline.

SILVERLON® burn products and protocols are extensively used by the US Army and by US Air Force Critical Care Air Transport (CCAT) teams and are taught at the US Air Force School of Aerospace Medicine Critical Care Air Transport Basic Course.

Beyond the military, SILVERLON® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds.

Argentum Medical continues to explore new applications and markets for its SILVERLON® technology in keeping with its corporate mission to improve clinical outcomes. For more about SILVERLON®, visit Silverlon.com.

ABOUT SILVERLON

SILVERLON® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. SILVERLON® was originally developed for the U.S. military, where it is still extensively used for management of burn and blast injuries. SILVERLON® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds. For more, visit Silverlon.com.

ABOUT ARGENTUM MEDICAL

Argentum Medical pioneered the use of silver-plated nylon. Specializing in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its SILVERLON® technology in keeping with its corporate mission to improve clinical outcomes.

###

Share article on social media or email:

Leave a Reply